Literature DB >> 22865883

Coordinated action of hypoxia-inducible factor-1α and β-catenin in androgen receptor signaling.

Takakazu Mitani1, Naoki Harada, Yoshihisa Nakano, Hiroshi Inui, Ryoichi Yamaji.   

Abstract

The androgen receptor (AR) acts as a ligand-dependent transcriptional factor and plays a critical role in the development and progression of androgen-dependent and castration-resistant prostate cancer. Castration results in hypoxia in prostate cancer cells, and hypoxia enhances transcriptional activity of AR through hypoxia-inducible factor (HIF)-1α at low serum androgen levels mimicking the castration-resistant stage. However, HIF-1α is necessary but not sufficient for hypoxia-activated AR transactivation, and the molecular mechanism that regulates AR function in castration-resistant prostate cancer remains unclear. Here, we report that β-catenin is required for HIF-1α-mediated AR transactivation in hypoxic LNCaP prostate cancer cells under low androgen conditions. HIF-1α and β-catenin coordinately enhanced AR N-terminal and C-terminal interaction. β-Catenin accumulated in the nucleus in the HIF-1α protein-positive cells of LNCaP xenografts in castrated mice. In LNCaP cells, when HIF-1α was knocked down or was exogenously expressed in the cytoplasm, hypoxia-induced nuclear localization of β-catenin was inhibited. β-Catenin formed a complex with HIF-1α both in the nucleus and in the cytoplasm. Hypoxia increased the amount of a complex composed of AR and β-catenin, and knockdown of HIF-1α attenuated the recruitment of AR and β-catenin to the androgen response elements (AREs) of androgen-responsive genes. Furthermore, together with β-catenin, HIF-1α bound to the AREs in the presence of androgen. These results demonstrate that (i) HIF-1α and β-catenin coordinately enhance AR transactivation by accelerating N-terminal and C-terminal interaction; (ii) HIF-1α promotes nuclear translocation of β-catenin in hypoxia; and (iii) AR, HIF-1α, and β-catenin form a ternary complex on AREs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865883      PMCID: PMC3460458          DOI: 10.1074/jbc.M112.388298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

Authors:  Udit N Verma; Rama M Surabhi; Aurelia Schmaltieg; Carlos Becerra; Richard B Gaynor
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

2.  Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment.

Authors:  Takakazu Mitani; Ryoichi Yamaji; Yasuki Higashimura; Naoki Harada; Yoshihisa Nakano; Hiroshi Inui
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-05       Impact factor: 4.292

3.  Detection and analysis of beta-catenin mutations in prostate cancer.

Authors:  D R Chesire; C M Ewing; J Sauvageot; G S Bova; W B Isaacs
Journal:  Prostate       Date:  2000-12-01       Impact factor: 4.104

4.  Linking beta-catenin to androgen-signaling pathway.

Authors:  Fajun Yang; Xiaoyu Li; Manju Sharma; Carl Y Sasaki; Dan L Longo; Bing Lim; Zijie Sun
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

5.  Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland.

Authors:  A Shabsigh; M A Ghafar; A de la Taille; M Burchardt; S A Kaplan; A G Anastasiadis; R Buttyan
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

6.  Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.

Authors:  Liang-Nian Song; Roger Herrell; Stephen Byers; Salimuddin Shah; Elizabeth M Wilson; Edward P Gelmann
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 7.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

8.  The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli.

Authors:  David J Mulholland; Helen Cheng; Kim Reid; Paul S Rennie; Colleen C Nelson
Journal:  J Biol Chem       Date:  2002-02-20       Impact factor: 5.157

9.  Formation of the androgen receptor transcription complex.

Authors:  Yongfeng Shang; Molly Myers; Myles Brown
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  29 in total

Review 1.  Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.

Authors:  Gagan Deep; Gati K Panigrahi
Journal:  Crit Rev Oncog       Date:  2015

2.  Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.

Authors:  Hong Chen; Hai-Xiang Shen; Yi-Wei Lin; Ye-Qing Mao; Ben Liu; Li-Ping Xie
Journal:  Cell Cycle       Date:  2018-08-02       Impact factor: 4.534

3.  Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.

Authors:  Elena V Fernandez; Kelie M Reece; Ariel M Ley; Sarah M Troutman; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

4.  Wnt signaling in castration-resistant prostate cancer: implications for therapy.

Authors:  Noriko N Yokoyama; Shujuan Shao; Bang H Hoang; Dan Mercola; Xiaolin Zi
Journal:  Am J Clin Exp Urol       Date:  2014-04-15

5.  Androgen Deprivation Therapy Potentiates the Efficacy of Vascular Targeted Photodynamic Therapy of Prostate Cancer Xenografts.

Authors:  Kwanghee Kim; Philip A Watson; Souhil Lebdai; Sylvia Jebiwott; Alexander J Somma; Stephen La Rosa; Dipti Mehta; Katie S Murray; Hans Lilja; David Ulmert; Sebastien Monette; Avigdor Scherz; Jonathan A Coleman
Journal:  Clin Cancer Res       Date:  2018-02-20       Impact factor: 12.531

6.  β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

Authors:  Jung Min Lee; Jing Yang; Pippa Newell; Sucha Singh; Anil Parwani; Scott L Friedman; Kari Nichole Nejak-Bowen; Satdarshan P Monga
Journal:  Cancer Lett       Date:  2013-09-23       Impact factor: 8.679

7.  Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.

Authors:  Le Tao; Jianxin Qiu; Ming Jiang; Wenbin Song; Shuyuan Yeh; Hong Yu; Lijuan Zang; Shujie Xia; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261

8.  Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice.

Authors:  Wafa Bouaziz; Johanna Sigaux; Dominique Modrowski; Claire-Sophie Devignes; Thomas Funck-Brentano; Pascal Richette; Hang-Korng Ea; Sylvain Provot; Martine Cohen-Solal; Eric Haÿ
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-27       Impact factor: 11.205

Review 9.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

10.  Knockdown of dickkopf2 inhibits vascular endothelia growth factor expression through the Wnt/β-catenin signaling pathway in human retinal pigment epithelial cells under hypoxic conditions.

Authors:  Yu Zhao; Bin Wu; Ye Liu; Jun Xu; Qichang Yan; Jinsong Zhang
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.